Search

Your search keyword '"Ficquet, Jo"' showing total 3 results
Start Over Author "Ficquet, Jo" Publication Type Magazines
3 results on '"Ficquet, Jo"'

1. Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial

Author

Hurrell, Alice, Webster, Louise, Sparkes, Jenie, Battersby, Cheryl, Brockbank, Anna, Clark, Katherine, Duhig, Kate E, Gill, Carolyn, Green, Marcus, Hunter, Rachael M, Seed, Paul T, Vowles, Zoe, Myers, Jenny, Shennan, Andrew H, Chappell, Lucy C, Ahuja, Ashwin, Alexander, Hazel, Arya, Rita, Bahl, Rachna, Bapir, Mihraban, Barry, Natalie, Basak, Sambita, Bishop, Linda, Biswas, Chandrima, Campbell, Deniesha, Chados, Nikolaos, Davies, Sarah, Davison, Jessica, Dudgeon, Lucy, Ferry, Orla, Ficquet, Jo, Girling, Jo, Gowans, Sharon, Hewitt, Lesley, Hinshaw, Kim, Holt, Siobhan, Jack, Elaine, Jennings, Jacqui, Maher, Martin, McBean, Mel, McDonnell, Sian, Mehta, Anku, Morris, Katie, O'Brien, Clare, Obiozo, Chinwe, Peers, Beth, Pickering, Francis, Regan, Maeve, Rich, Mel, Roughley, Lindsay, Ryan, Grace, Sharp, Andrew, Smart, Brittany, Smith, Annabel, Stirrat, Laura, Thompson, Hilary, Trepte, Lauren, Verghese, Lynda, Willson, Seren, and Yulia, Angela

Abstract

Placental growth factor (PlGF)-based testing has high diagnostic accuracy for predicting pre-eclampsia needing delivery, significantly reducing time to diagnosis and severe maternal adverse outcomes. The clinical benefit of repeat PlGF-based testing is unclear. We aimed to determine whether repeat PlGF-based testing (using a clinical management algorithm and nationally recommended thresholds) reduces adverse perinatal outcomes in pregnant individuals with suspected preterm pre-eclampsia.

Published
2024
Full Text
View/download PDF

2. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial

Author

Chappell, Lucy C, Brocklehurst, Peter, Green, Marcus E, Hunter, Rachael, Hardy, Pollyanna, Juszczak, Edmund, Linsell, Louise, Chiocchia, Virginia, Greenland, Melanie, Placzek, Anna, Townend, John, Marlow, Neil, Sandall, Jane, Shennan, Andrew, Agarwal, Umber, Ahmed, Irshad, Ajay, Bini, Alfirevic, Zarko, Arya, Rita, Bambridge, Gabrielle, Bamfo, Jacqueline, Basak, Sambita, Bowler, Ursula, Cameron, Helen, Churchill, David, Cresswell, Janet, Crosfill, Fiona, Denbow, Mark, Dey, Madhuchanda, Everden, Caroline, Ficquet, Jo, Gajewska-Knapik, Katarzyna, Ganapathy, Ramesh, Garrett, Angela, Girling, Joanna, Gornall, Adam, Harding, Kate, Hendy, Eleanor, Howard, Richard, James, Mark, Johnson, Antoinette, Kemp, Michelle, Khalil, Asma, Khan, Rehan, Khan, Rahila, Knox, Ellen, Margarit, Lavinia, Marsden, Philippa, McIntyre, Karen, Myers, Jenny, Nugent, Justine, Rao, Sanjay, Robinson, Zoey, Robson, Stephen, Rushby, Pauline, Scholz, Laura, Shahin, Mohamed, Sharma, Bhavna, Simpson, Nigel, Singh, Natasha, Sparkes, Jenie, Stone, Sophia, Subair, Seni, Tan, Bee, Thakur, Vidya, Thamban, Sujatha, Thornton, Jim, Thornton, Jim, Tohill, Sue, Tsoi, Elly, Tuffnell, Derek, Waterstone, Mark, Waugh, Jason, Wiesender, Cornelia, and Wu, Pensee

Abstract

In women with late preterm pre-eclampsia, the optimal time to initiate delivery is unclear because limitation of maternal disease progression needs to be balanced against infant complications. The aim of this trial was to determine whether planned earlier initiation of delivery reduces maternal adverse outcomes without substantial worsening of neonatal or infant outcomes, compared with expectant management (usual care) in women with late preterm pre-eclampsia.

Published
2019
Full Text
View/download PDF

3. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial

Author

Duhig, Kate E, Myers, Jenny, Seed, Paul T, Sparkes, Jenie, Lowe, Jessica, Hunter, Rachael M, Shennan, Andrew H, Chappell, Lucy C, Bahl, Rachna, Bambridge, Gabrielle, Barnfield, Sonia, Ficquet, Jo, Gill, Carolyn, Girling, Joanna, Harding, Kate, Khalil, Asma, Sharp, Andrew, Simpson, Nigel, and Tuffnell, Derek

Abstract

Previous prospective cohort studies have shown that angiogenic factors have a high diagnostic accuracy in women with suspected pre-eclampsia, but we remain uncertain of the effectiveness of these tests in a real-world setting. We therefore aimed to determine whether knowledge of the circulating concentration of placental growth factor (PlGF), an angiogenic factor, integrated with a clinical management algorithm, decreased the time for clinicians to make a diagnosis in women with suspected pre-eclampsia, and whether this approach reduced subsequent maternal or perinatal adverse outcomes.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results